Michael S Bagwell1, Kevin E Wilk, Ricardo E Colberg2, Jeffrey R Dugas3. 1. Orthopaedic Sports Medicine PT Fellow, Champion Sports Medicine, Birmingham, AL. 2. Non-Operative Orthopaedist, Andrews Sports Medicine & Orthopaedic Center, Birmingham, AL. 3. Orthopaedic Surgeon, Andrews Sports Medicine & Orthopaedic Center, Birmingham, AL.
Abstract
BACKGROUND: Medial collateral ligament (MCL) injuries are one of the most commonly treated knee pathologies in sports medicine. The MCL serves as the primary restraint to valgus force. The large majority of these injuries do not require surgical intervention. CASE SUBJECT DESCRIPTION: A 30-year-old professional wrestling athlete presented to the clinic with acute complaints of right medial knee pain resulting from a traumatic valgus force. Physical exam revealed Grade 3 MCL injury. Magnetic resonance imaging confirmed clinical diagnosis of a Grade 3 proximal MCL tear. This athlete had sustained a prior grade 3 ACL injury with Grade 3 distal MCL injury which required surgery to reconstruct the ACL and repair the MCL 13 months prior, in November of 2015. OUTCOMES: The subject was successfully treated with a series of three sequential Leukocyte Rich Platelet Rich Plasma (LR-PRP) Injections spaced evenly one week apart in addition to an early physical therapy regimen. The total treatment time was cut down from an expected 35-49 days to 31 days. DISCUSSION: When paired with the appropriate rehabilitation treatment progression, the use of LR-PRP injections in the treatment of an isolated MCL tear was beneficial for this subject. CONCLUSION: The results of this case report indicate that the use of LR-PRP and early rehabilitation shows promise in treating an acute grade 3 MCL injury. Future research utilizing randomized controlled trials are needed. LEVEL OF EVIDENCE: Case Report, 4.
BACKGROUND: Medial collateral ligament (MCL) injuries are one of the most commonly treated knee pathologies in sports medicine. The MCL serves as the primary restraint to valgus force. The large majority of these injuries do not require surgical intervention. CASE SUBJECT DESCRIPTION: A 30-year-old professional wrestling athlete presented to the clinic with acute complaints of right medial knee pain resulting from a traumatic valgus force. Physical exam revealed Grade 3 MCL injury. Magnetic resonance imaging confirmed clinical diagnosis of a Grade 3 proximal MCL tear. This athlete had sustained a prior grade 3 ACL injury with Grade 3 distal MCL injury which required surgery to reconstruct the ACL and repair the MCL 13 months prior, in November of 2015. OUTCOMES: The subject was successfully treated with a series of three sequential Leukocyte Rich Platelet Rich Plasma (LR-PRP) Injections spaced evenly one week apart in addition to an early physical therapy regimen. The total treatment time was cut down from an expected 35-49 days to 31 days. DISCUSSION: When paired with the appropriate rehabilitation treatment progression, the use of LR-PRP injections in the treatment of an isolated MCL tear was beneficial for this subject. CONCLUSION: The results of this case report indicate that the use of LR-PRP and early rehabilitation shows promise in treating an acute grade 3 MCL injury. Future research utilizing randomized controlled trials are needed. LEVEL OF EVIDENCE: Case Report, 4.
Authors: G C Leitner; R Gruber; J Neumüller; A Wagner; P Kloimstein; P Höcker; G F Körmöczi; C Buchta Journal: Vox Sang Date: 2006-08 Impact factor: 2.144
Authors: Robert F LaPrade; Andrew G Geeslin; Iain R Murray; Volker Musahl; Jason P Zlotnicki; Frank Petrigliano; Barton J Mann Journal: Am J Sports Med Date: 2016-03-29 Impact factor: 6.202
Authors: Steve Tumilty; Joanne Munn; Suzanne McDonough; Deirdre A Hurley; Jeffrey R Basford; G David Baxter Journal: Photomed Laser Surg Date: 2010-02 Impact factor: 2.796
Authors: Christina Freiberger; Ata M Kiapour; Shanshan Liu; Rachael N Henderson; Samuel Barnett; Nicholas J Sant; Benedikt L Proffen; Braden C Fleming; Kirsten Ecklund; Dennis E Kramer; Lyle J Micheli; Martha M Murray; Yi-Meng Yen Journal: Orthop J Sports Med Date: 2020-07-01